Frankfurt-am-Main, Germany

Gerhard Breipohl



Average Co-Inventor Count = 3.5

ph-index = 11

Forward Citations = 282(Granted Patents)


Location History:

  • Frankurt, DE (1998)
  • Frankhurt, DE (2000)
  • Frankfurt-am-Main, DE (1989 - 2011)
  • Hilden, DE (2012)

Company Filing History:


Years Active: 1989-2012

Loading Chart...
Loading Chart...
44 patents (USPTO):Explore Patents

Title: Gerhard Breipohl – Innovator in Polymide Nucleic Acid Derivatives

Introduction

Gerhard Breipohl is a renowned inventor based in Frankfurt-am-Main, Germany, known for his significant contributions to the field of nucleic acid chemistry. With an impressive portfolio of 44 patents, Breipohl has been instrumental in developing innovative solutions that bridge the gaps in pharmaceutical and diagnostic applications.

Latest Patents

Breipohl's latest inventions include advanced polymide nucleic acid derivatives. These new PNA derivatives feature phosphoryl radicals attached to both the C and N termini of the PNA backbone. The introduced phosphoryl radicals can carry various functional groups, such as labeling groups for detection, crosslinking agents, and elements that enhance intracellular uptake or binding affinity to nucleic acids. The implications of these patents extend to their use as pharmaceuticals and diagnostic agents, reflecting Breipohl’s focus on making tangible impacts in healthcare.

Career Highlights

Throughout his career, Breipohl has contributed to prestigious companies, including Hoechst Aktiengesellschaft and Aventis Pharma Deutschland GmbH. His work has helped solidify the roles of these companies in the biopharmaceutical sector, paving the way for innovative therapeutic solutions.

Collaborations

Breipohl's success can be attributed to his collaborations with esteemed colleagues, such as Jochen Knolle and Eugen Uhlmann. Their teamwork has fostered a creative environment where groundbreaking ideas could flourish and lead to impactful innovations in the field of nucleic acids.

Conclusion

Gerhard Breipohl stands as a prominent figure in the realm of scientific innovation, particularly in the development of polymide nucleic acid derivatives. His extensive patent portfolio and collaborative efforts underscore his commitment to advancing the field of biomedicine. As research continues to progress, the applications of his inventions promise to enhance diagnostic and therapeutic techniques, ultimately benefiting the broader health community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…